9C
Delhi
Saturday, January 16, 2021

HCQ has 90% chance of helping COVID-19 patients: US doctors” body

- Advertisement -

Governemtn pro-actively speeding up production of essential medicinesNew York, April 30 (IANS) A team of US doctors has claimed that hydroxychloroquine, an anti-malarial drug termed potential “game-changer” for COVID-19 by President Donald Trump, has improved the survival and recovery odds for about 90 per cent of patients infected with the virus.

In a letter to Arizona Governor Doug Ducey, the Association of American Physicians and Surgeons (AAPS) presented a frequently updated table of studies that report results of treating COVID-19 with the chloroquine and hydroxychloroquine drugs.

They presented data on 2,333 patients treated with hydroxychloroquine in China, France, South Korea, Algeria, and the US.

It shows 91.6 per cent of those who got the drug fared better after treatment.

The antiviral properties of these drugs have been studied since 2003. Particularly when combined with zinc, they hinder viral entry into cells and inhibit replication. They may also prevent overreaction by the immune system, which causes the cytokine storm responsible for much of the damage in severe cases, the AAPS explained.

READ ALSO:  UNHRC draws world-wide flak over election of China & Pak as members

In a letter, the AAPS team urged that doctors should not wait for results of gold standard tests of the drug to start using it for coronavirus patients and should instead base their use of it on reasonable interpretations of limited available data.

Peer-reviewed studies published from January through April 20, this year, provide clear and convincing evidence that hydroxychloroquine may be beneficial in COVID-19, especially when used early, they stated.

AAPS”s endorsement of the drug comes after the study from Veterans Health Administration medical centres showed that hydroxychloroquine has no benefit in treating patients with the disease.

READ ALSO:  Dhoni will finish with no regrets on the field: Ganguly

Meanwhile, on April 24, the US Food and Drug Administration (FDA) issued fresh guidelines, cautioning people against over-the-counter use of hydroxychloroquine or chloroquine for Covid-19 outside of the hospital setting or a clinical trial due to the risk of heart rhythm problems.

READ ALSO:  Rs 170,000 cr relief package announced by centre for COVID fund

The FDA said it is aware of reports of serious heart rhythm problems in patients with Covid-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT-prolonging medicines.

“We are also aware of the increased use of these medicines through outpatient prescriptions. Therefore, we would like to remind healthcare professionals and patients of the known risks associated with both hydroxychloroquine and chloroquine,” the agency said in a statement.

–IANS

bu/na

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India

Over 22 bn records exposed in data breaches in 2020: Report

New Delhi, Jan 15 (IANS): Over 22 billion records were exposed worldwide amid 730 publicly disclosed data breaches in 2020, a new report revealed on...

Xiaomi may bring 80W wireless charging to the Mi 11 Pro

Beijing, Jan 15 (IANS) Xiaomi is planning to launch the Pro version of its recently announced flagship smartphone Mi 11 with a new report...

Centre may intimate qualified bidders for Air India by Jan 30

New Delhi, Jan 15 (IANS): The Centre is likely to intimate the qualified bidders for national carrier Air India by the end of the month, as...

Stalemate over farm laws continues, next meeting on Jan 19

New Delhi, Jan 15 (IANS) The ninth round of talks between the government and the agitating farmers ended inconclusively on Friday. The next round...